RecruitingNot Applicable

Evaluation of Platelet-Rich Plasma (PRP) Treatment in Tendinopathies

Spain2,000 participantsStarted 2026-04

Plain-language summary

This multicenter, prospective, observational study, based on real-world evidence (RWE), aims to evaluate the efficacy and safety of Platelet-Rich Plasma (PRP) treatment across four types of tendinopathies: patellar, Achilles, epicondylar, and plantar fasciosis. Data collection and analysis will be conducted using the BioSmartData® platform, including hematology analyzers for PRP characterization, clinical variables, treatment protocols, and longitudinal assessment of therapeutic response.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinical and/or ultrasound diagnosis of chronic tendinopathy (duration \>6 weeks) * Age \>18 years * Provision of written informed consent * Willingness and ability to complete follow-up assessments for 12 months Exclusion Criteria: * Surgical treatment of the affected tendon within the previous 6 months * Corticosteroid injection within the last month * Systemic inflammatory disease (e.g., rheumatoid arthritis) * Coagulopathies or ongoing anticoagulant therapy * Complete blood count showing a platelet concentration \<100 × 10⁹/L (to exclude patients with potential thrombocytopenia) * Pregnancy or breastfeeding

What they're measuring

Visual Analog Scale

Timeframe: From baseline up to 12 months post-treatment

VISA-P

Timeframe: baseline, 1 month, 3 months, 6 months and 12 months

VISA-A

Timeframe: baseline, 1 month, 3 months, 6 months and 12 months

Patient Rated Tennis Elbow Evaluation Scale

Timeframe: baseline, 1 month, 3 months, 6 months and 12 months

Foot Function Index

Timeframe: baseline, 1 month, 3 months, 6 months and 12 months

Trial details

NCT IDNCT07558564

SponsorReSport Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-03

Contact for this trial

Resport Clinic, MD PhD

+34 93 2778709 abat@resportclinic.com

View on ClinicalTrials.gov More Patellar Tendinopathy trials

Plain-language summary

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Visual Analog Scale

Timeframe: From baseline up to 12 months post-treatment

VISA-P

Timeframe: baseline, 1 month, 3 months, 6 months and 12 months

VISA-A

Timeframe: baseline, 1 month, 3 months, 6 months and 12 months

Patient Rated Tennis Elbow Evaluation Scale

Timeframe: baseline, 1 month, 3 months, 6 months and 12 months

Foot Function Index

Timeframe: baseline, 1 month, 3 months, 6 months and 12 months